Thursday, June 20, 2019 9:10:38 AM
first and only solution indicated for mmTBI
pilot studies for MS, CP, stroke..all with similar results across all symptoms
350k Canadians with mmTBI
1.5MM Americans
120k new cases every year in USA
product stimulates trigeminal nerve via tongue
IP whitespace (tongue-based brain stimulation entirely unexplored before today)
60 patents covering method and utility
increases blood supply to brain
neuromodulation combined with phsy/cog therapy leads to brain rebuilding itself (neurplasticity)
shown efficacious on patients who have undergone every other available therapy, and are no longer improving, even after an average of 4 years since last treatment
study was patients who are all treatment resistant and min 1 year later (chronic symptoms set in, lifetime affliction virtual certainty)
120 person trial
50% of them regained normal balance after the trial
efficacy retained 3mo after last use of device, proving the remedy is permanent
Cleared in Canada, commercialization underway
cleared in Russia (partners in place)
EU clearance submission filed in Dec 2018
AU submitted in May 2019
expect AU verdict in summer 2019
FDA rejected "de novo" classification, so back to FDA around Sept to get detailed guidance
not waiting.. generating a random PT-only trial now
Canada alone is "multi-billion dollar business" just for mmTBI indication
device sales is focus, partners and clinic drive service
2 founding clinics in CA
3 more clinics in CA just signed (now over 50% of population have access)
*data due in summer about patient outcomes*, prelim is encouraging
PoNS is a platform tech
peer-reviewed studies on MS
AU publication on stroke
other neurological conditions likely
$19MM in cash at the end of Q1
$700k in revenue last year
2019 guidance: $1.6-2MM in revenue from the 2 initial CA clinics alone (though they already signed 3 more)
early Aug will report Q2 numbers and update guidance
JMP Conference webcast from June 2019: http://wsw.com/webcast/jmp39/hsdt/index.aspx
Latest Investor deck: https://heliusmedical.com/images/pdf/Presentation/2019/HSDT_Company_Public_Presentation_v_2.1_MLR_Approved_5232019.pdf
Video supposedly showing one child's result from PoNS treatment in Russia: https://vimeo.com/181665292
and to offer an alternative perspective, a bearish SA article from Jan: https://seekingalpha.com/article/4234256-helius-medical-failed-clinical-trial-redacted-data-questionable-leadership-points-ineffective
Recent HSDT News
- Helius Medical Technologies, Inc. Announces PoNS® Is Now Available on the Veterans Affairs (VA) Federal Supply Schedule (FSS) and General Services Administration (GSA) Advantage Contracts • GlobeNewswire Inc. • 05/20/2024 01:00:00 PM
- Form SC 13G - Statement of acquisition of beneficial ownership by individuals • Edgar (US Regulatory) • 05/14/2024 08:15:39 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 05/13/2024 08:30:46 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 05/13/2024 08:15:00 PM
- Helius Medical Technologies, Inc. Reports First Quarter 2024 Financial Results • GlobeNewswire Inc. • 05/13/2024 08:05:00 PM
- Helius Medical Technologies, Inc. to Release First Quarter 2024 Financial Results on May 13, 2024 • GlobeNewswire Inc. • 05/10/2024 01:00:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 05/09/2024 08:31:03 PM
- Form 424B4 - Prospectus [Rule 424(b)(4)] • Edgar (US Regulatory) • 05/08/2024 08:56:46 PM
- Helius Medical Technologies, Inc. Announces Pricing of $6.4 Million Public Offering • GlobeNewswire Inc. • 05/07/2024 02:15:00 AM
- Helius Medical Technologies, Inc. Announces Preliminary CMS Payment Determination of Reimbursement for Portable Neuromodulation Stimulator (PoNS®) • GlobeNewswire Inc. • 05/06/2024 01:00:00 PM
- Helius Medical Technologies, Inc. Expands Stroke Clinical Program with Participation of Shepherd Center • GlobeNewswire Inc. • 04/24/2024 01:05:00 PM
- Helius Medical Technologies, Inc. Announces Partnership with Lovell® Government Services to Expand Reach of PoNS Therapy™ • GlobeNewswire Inc. • 04/03/2024 11:05:00 AM
- Helius Medical Technologies, Inc. Reports Fourth Quarter and Full Year 2023 Financial Results • GlobeNewswire Inc. • 03/28/2024 08:05:00 PM
- Helius Medical Technologies, Inc. to Release Fourth Quarter and Full Year 2023 Financial Results on March 28, 2024 • GlobeNewswire Inc. • 03/15/2024 11:05:00 AM
- Helius Medical Technologies, Inc. Initiates Open-Label Study for Registrational Program in Stroke • GlobeNewswire Inc. • 03/12/2024 12:59:22 PM
- Helius Medical Technologies, Inc. to Present at the 36th Annual ROTH Conference • GlobeNewswire Inc. • 03/07/2024 12:00:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 03/04/2024 12:30:51 PM
- Helius Medical Technologies, Inc. Secures HCPCS Codes for Portable Neuromodulation Stimulator (PoNS®) Mouthpiece and Controller • GlobeNewswire Inc. • 03/04/2024 12:00:00 PM
- Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] • Edgar (US Regulatory) • 02/14/2024 12:09:07 AM
- Form 8-K - Current report • Edgar (US Regulatory) • 02/09/2024 09:15:49 PM
- Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] • Edgar (US Regulatory) • 02/06/2024 03:22:13 PM
- Helius Medical Technologies, Inc. Announces Alignment with FDA on Registrational Program for Treatment of Stroke Patients • GlobeNewswire Inc. • 02/06/2024 12:00:00 PM
- Helius Booth and Special Event at APTA Combined Sections Meeting Will Highlight Physical Therapists’ Ability to Customize PoNS Therapy® to Improve Gait in People with MS • GlobeNewswire Inc. • 02/05/2024 12:05:00 PM
- Helius Medical Technologies, Inc. Announces Further Expansion of Stroke Clinical Program with the Addition of Brooks Rehabilitation Hospital • GlobeNewswire Inc. • 01/11/2024 12:00:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 12/04/2023 02:00:31 PM
"Defo's Morning Briefing" Set to Debut for "GreenliteTV" • GRNL • May 21, 2024 2:28 PM
North Bay Resources Announces 50/50 JV at Fran Gold Project, British Columbia; Initiates NI 43-101 Resources Estimate and Bulk Sample • NBRI • May 21, 2024 9:07 AM
Greenlite Ventures Inks Deal to Acquire No Limit Technology • GRNL • May 17, 2024 3:00 PM
Music Licensing, Inc. (OTC: SONG) Subsidiary Pro Music Rights Secures Final Judgment of $114,081.30 USD, Demonstrating Strength of Licensing Agreements • SONGD • May 17, 2024 11:00 AM
VPR Brands (VPRB) Reports First Quarter 2024 Financial Results • VPRB • May 17, 2024 8:04 AM
ILUS Provides a First Quarter Filing Update • ILUS • May 16, 2024 11:26 AM